Drugs / R-Star001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07101549 | Aug 2025 → Aug 2027 expected | cancer | changjianhua | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | R-Star001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07101549 ↗ |
| Known as | Nectin-4-CART-IL18 | “Treating Nectin-4-positive Advanced Solid Tumors With R-Star001 (Nectin-4-CART-IL18)” NCT07101549 ↗ |
| Modality | Cell therapy | “Nectin-4-targeted CAR T-cell injection” NCT07101549 ↗ |